This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
10 Jan 2020  |  Asia Pacific  |  Market Research
Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
$10,000.00 -
19 Dec 2014  |  Asia Pacific  |  Market Research
Patent Cliff and the Future of Generics in Asia
Trends that will Impact the Market in the Short Term
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...
$2,450.00 -
15 Nov 2014  |  Asia Pacific  |  Market Research
Thailand In Vitro Diagnostics Market
Snapshot of Demand and Investment Opportunities
The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and mic...
$2,450.00 -
17 Sep 2014  |  Asia Pacific  |  Market Research
Analysis of the Chinese Breast Imaging Systems Market
Technology Enhancements Accelerate the Growth of Diagnostic Imaging
This research service provides the market revenues and trends of various breast imaging modalities in the Chinese market. Increasing incidence of breast cancer, awareness among the population, healthcare reforms, and expansion of breast screening to rural areas accelerate the growth of breast imaging market in China. Increasing disposable income, ...
$3,950.00 -
12 Aug 2014  |  Asia Pacific  |  Market Research
Malaysia Healthcare Outlook
Showcasing Value Propositions for Investors
The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...
$3,950.00 -
24 Jul 2014  |  Asia Pacific  |  Market Research
Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia Pacific
This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.
$500.00 -
03 Jul 2014  |  Asia Pacific  |  Market Outlook
2014 Asia-Pacific Medical Devices Outlook
Changing Demographics and Landscape Set Stage for the Future
Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...
$3,950.00 -
28 May 2014  |  Asia Pacific  |  Market Research
Profiling of Top 50 Healthcare Service Providers in Asia-Pacific
A Deep-dive Analysis of the Business and Financial Health of Leading Companies in the Region
Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...
$4,950.00 -
26 May 2014  |  Asia Pacific  |  Market Research
Indonesian Infectious Disease IVD Market
Mapping the Market for Investment, Best Practices, and Growth Potential
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...
$4,950.00 -
23 May 2014  |  Asia Pacific  |  Market Research
Western European Companion Diagnostics Market
Regulatory Hurdles and LDTs Stall the Global and European Market for Companion Diagnostics
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...
$4,950.00